CSI Market
Sign In | Register

10x Genomics Inc (TXG) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TXG Annual Balance Sheets →
The data below summarizes 10x Genomics Inc's balance sheet position from Jun 30 2025 to Jun 30 2026, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent502.51
Available-for-sale Securities, Debt Securities, Current MA49.55
Cash & Short-term Investments551.00
Accounts receivable47.55
Other Receivables, Net, Current3.08
Inventories52.62
Prepaid Expense And Other Assets Current19.39
Total Current Assets674.67
Equipment/Property/Plant Net383.08
Goodwill net6.92
Intangible Assets61.16
Other Assets, Noncurrent0.00
Restricted Cash Noncurrent-
Total Assets1,030.07
Liabilities
Accounts Payable, Current AC20.69
Employee-related Liabilities, Current AC24.74
Estimated Litigation Liability, Current0.00
Other Liabilities, Current66.13
Taxes Payable6.95
Total Current Liabilities118.51
Total Long-term Debt0.00
Estimated Litigation Liability, Noncurrent LI0.00
Other liabilities, Noncurrent86.01
Contract With Customer Liability Current24.34
Contract With Customer Liability Noncurrent10.14
Operating Lease Liability Noncurrent70.06
Total Liabilities204.52
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock2,367.46
Retained Earnings / Accumulated Deficit-1,541.99
Accumulated Other Comprehensive Income0.08
Other Equity0.08
Common Stockholder's Equity825.55
Total Stockholder's Equity825.55
Liabilities & Stockholder's Equity1,030.07
4 historic quarters locked

Sign in to unlock the full 10x Genomics Inc balance sheet history.

Sign In Create Free Account

About 10X Genomics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 6, 2026
  • Source: txg-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-054491

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.